Chargement des cours...
Prévisions
| Acheter |
1 |
| Conserver |
0 |
| Vendre |
0 |
Actualités Accéder au fil d'actualités
Supply stoppages weigh on Olympus: 2026 sales forecast cut 2% on a constant-currency basis
For Q3 of fiscal 2026 Olympus reported sales of 2,610 Oku Yen (+4% on a constant-currency basis) and adjusted operating profit of 393 Oku Yen (margin 15.1%). Due to supply stoppages of about 90 Oku Yen caused by FDA inspections, the company lowered its sales forecast excluding currency effects by 2% but kept its operating margin targets unchanged (now 12.7–13.9%). CEO Bob White announced measures to remedy the supply issues, strengthen quality and regulatory teams, and implement strategic initiatives to improve margins and growth; the stock fell 5.22% after the announcement. » Plus sur de.investing.com
Données financières de l'entreprise
| (EUR) | juin 2026 | |
|---|---|---|
| Chiffre d'affaires | 1,31Md | 7,94% |
| Bénéfice brut | 856,00M | 7,62% |
| Bénéfice net | 104,26M | 97,01% |
| EBITDA | 268,02M | 56,17% |
Données fondamentales
| Indicateur | Valeur |
|---|---|
Capitalisation boursière | 12,17Md€ |
Nombre d'actions | 1,06Md |
Plus haut/bas sur 52 semaines | 11,80€ - 6,94€ |
| Dividendes | Non |
Bêta | 0,21 |
Ratio P/E | 30,88 |
Ratio PEG | −1,11 |
Ratio P/B | 3,16 |
Ratio P/S | 2,32 |
Profil de l'entreprise
| Nom | OLYMPUS CORP. ADR |
| PDG | Robert White |
| Employés | 28.138 |
Découvrir des actifs
Les actionnaires de OLYMPUS CORP. ADR investissent également dans les actifs suivants
